Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit

Background. Multidrug-resistant Acinetobacter (MDR-Ab) is one of the most important pathogens causing superinfections in COVID-19 patients hospitalised in the intensive care unit (ICU). The occurrence of MDR-Ab superinfection significantly impairs the prognosis of patients in the ICU. Overuse of ant...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Mihalov, J. Hodosy, A. Koščálová, M. Čaprnda, M. Kachlíková, J. Jurenka, M. Bendžala, P. Sabaka
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2023/4951273
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559608896421888
author P. Mihalov
J. Hodosy
A. Koščálová
M. Čaprnda
M. Kachlíková
J. Jurenka
M. Bendžala
P. Sabaka
author_facet P. Mihalov
J. Hodosy
A. Koščálová
M. Čaprnda
M. Kachlíková
J. Jurenka
M. Bendžala
P. Sabaka
author_sort P. Mihalov
collection DOAJ
description Background. Multidrug-resistant Acinetobacter (MDR-Ab) is one of the most important pathogens causing superinfections in COVID-19 patients hospitalised in the intensive care unit (ICU). The occurrence of MDR-Ab superinfection significantly impairs the prognosis of patients in the ICU. Overuse of antibiotics in COVID-19 patients might contribute to the risk of developing MDR-Ab infection. Objective. The objective was to assess the role of prior antibiotic exposure as an independent predictor of MDR-Ab infection in COVID-19 patients admitted to the ICU. Methods. We conducted a retrospective cohort study in 90 patients admitted to the ICU of the Department of Infectology and Geographical Medicine, University Hospital in Bratislava, for respiratory failure due to COVID-19 between 1 September 2021 and 31 January 2022 (delta variant predominance). Patients underwent regular microbial screening. Superinfection was defined as infection occurring ≥48 h after admission. We assessed the role of prior antibiotic exposure and other factors as independent predictors of MDR-Ab isolation. Results. Fifty-eight male and 32 female patients were included in the analysis. Multidrug-resistant bacteria were cultured in 43 patients (47.8%), and MDR-Ab was isolated in 37 patients. Thirty-three (36.7%) patients had superinfection caused by MDR-Ab. Fifty-four (60%) patients were exposed to antibiotics prior to MDR-Ab isolation; of those, 35 (64.8%) patients received ceftriaxone. Prior exposure to ceftriaxone (odds ratio (OR) 4.1; 95% confidence interval (CI) 1.4–11.9; P<0.05), tocilizumab therapy (OR 4.7; 95% CI 1.3–15.0; P< 0.05), and ICU length of stay exceeding 11 days (OR 3.7; 95% CI 1.3–10.3; P< 0.05) were independent predictors of MDR-Ab infection. Conclusions. Prior exposure to ceftriaxone increases the risk of MDR-Ab infection in COVID-19 patients admitted to the ICU. Our findings suggest that antibiotic use in COVID-19 patients admitted to the ICU should be restricted to patients with documented bacterial superinfection.
format Article
id doaj-art-1d34177c90e24e6ab23d7fe9dc638b4f
institution Kabale University
issn 1918-1493
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-1d34177c90e24e6ab23d7fe9dc638b4f2025-02-03T01:29:34ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932023-01-01202310.1155/2023/4951273Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care UnitP. Mihalov0J. Hodosy1A. Koščálová2M. Čaprnda3M. Kachlíková4J. Jurenka5M. Bendžala6P. Sabaka7Department of Infectology and Geographical MedicineEmergency DepartmentDepartment of Infectology and Geographical Medicine1st Department of Internal MedicineDepartment of Infectology and Geographical MedicineDepartment of Infectology and Geographical MedicineDepartment of Infectology and Geographical MedicineDepartment of Infectology and Geographical MedicineBackground. Multidrug-resistant Acinetobacter (MDR-Ab) is one of the most important pathogens causing superinfections in COVID-19 patients hospitalised in the intensive care unit (ICU). The occurrence of MDR-Ab superinfection significantly impairs the prognosis of patients in the ICU. Overuse of antibiotics in COVID-19 patients might contribute to the risk of developing MDR-Ab infection. Objective. The objective was to assess the role of prior antibiotic exposure as an independent predictor of MDR-Ab infection in COVID-19 patients admitted to the ICU. Methods. We conducted a retrospective cohort study in 90 patients admitted to the ICU of the Department of Infectology and Geographical Medicine, University Hospital in Bratislava, for respiratory failure due to COVID-19 between 1 September 2021 and 31 January 2022 (delta variant predominance). Patients underwent regular microbial screening. Superinfection was defined as infection occurring ≥48 h after admission. We assessed the role of prior antibiotic exposure and other factors as independent predictors of MDR-Ab isolation. Results. Fifty-eight male and 32 female patients were included in the analysis. Multidrug-resistant bacteria were cultured in 43 patients (47.8%), and MDR-Ab was isolated in 37 patients. Thirty-three (36.7%) patients had superinfection caused by MDR-Ab. Fifty-four (60%) patients were exposed to antibiotics prior to MDR-Ab isolation; of those, 35 (64.8%) patients received ceftriaxone. Prior exposure to ceftriaxone (odds ratio (OR) 4.1; 95% confidence interval (CI) 1.4–11.9; P<0.05), tocilizumab therapy (OR 4.7; 95% CI 1.3–15.0; P< 0.05), and ICU length of stay exceeding 11 days (OR 3.7; 95% CI 1.3–10.3; P< 0.05) were independent predictors of MDR-Ab infection. Conclusions. Prior exposure to ceftriaxone increases the risk of MDR-Ab infection in COVID-19 patients admitted to the ICU. Our findings suggest that antibiotic use in COVID-19 patients admitted to the ICU should be restricted to patients with documented bacterial superinfection.http://dx.doi.org/10.1155/2023/4951273
spellingShingle P. Mihalov
J. Hodosy
A. Koščálová
M. Čaprnda
M. Kachlíková
J. Jurenka
M. Bendžala
P. Sabaka
Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
Canadian Journal of Infectious Diseases and Medical Microbiology
title Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
title_full Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
title_fullStr Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
title_full_unstemmed Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
title_short Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit
title_sort antimicrobial therapy as a risk factor of multidrug resistant acinetobacter infection in covid 19 patients admitted to the intensive care unit
url http://dx.doi.org/10.1155/2023/4951273
work_keys_str_mv AT pmihalov antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT jhodosy antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT akoscalova antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT mcaprnda antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT mkachlikova antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT jjurenka antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT mbendzala antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit
AT psabaka antimicrobialtherapyasariskfactorofmultidrugresistantacinetobacterinfectionincovid19patientsadmittedtotheintensivecareunit